» Articles » PMID: 19013003

Glycosylphosphatidylinositol-anchored Protein Deficiency Confers Resistance to Apoptosis in PNH

Overview
Journal Exp Hematol
Specialty Hematology
Date 2008 Nov 18
PMID 19013003
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Investigate the contribution of PIG-A mutations to clonal expansion in paroxysmal nocturnal hemoglobinuria (PNH).

Materials And Methods: Primary CD34+ hematopoietic progenitors from PNH patients were assayed for annexin-V positivity by flow cytometry in a cell-mediated killing assay using autologous effectors from PNH patients or allogeneic effectors from healthy controls. To specifically assess the role of the PIG-A mutation in the development of clonal dominance and address confounders of secondary mutation and differential immune attack that can confound experiments using primary cells, we established an inducible PIG-A CD34+ myeloid cell line, TF-1. Apoptosis resistance was assessed after exposure to allogeneic effectors, NK92 cells (an interleukin-2-dependent cell line with the phenotype and function of activated natural killer [NK] cells), tumor necrosis factor (TNF)-alpha, and gamma-irradiation. Apoptosis was measured by annexin-V staining and caspase 3/7 activity.

Results: In PNH patients, CD34+ hematopoietic progenitors lacking glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-AP(-)) were less susceptible than GPI-AP+ CD34+ precursors to autologous (8% vs 49%; p < 0.05) and allogeneic (28% vs 58%; p < 0.05) cell-mediated killing from the same patients. In the inducible PIG-A model, GPI-AP(-) TF-1 cells exhibited less apoptosis than induced, GPI-AP+ TF-1 cells in response to allogeneic cell-mediated killing, NK92-mediated killing, TNF-alpha, and gamma-irradiation. GPI-AP(-) TF-1 cells maintained resistance to apoptosis when effectors were raised against GPI-AP(-) cells, arguing against a GPI-AP being the target of immune attack in PNH. NK92-mediated killing was partially inhibited with blockade by specific antibodies to the stress-inducible GPI-AP ULBP1 and ULBP2 that activate immune effectors. Clonal competition experiments demonstrate that the mutant clone expands over time under proapoptotic conditions with TNF-alpha.

Conclusion: PIG-A mutations contribute to clonal expansion in PNH by conferring a survival advantage to hematopoietic progenitors under proapoptotic stresses.

Citing Articles

Somatic mutations in Brazilian patients with paroxysmal nocturnal hemoglobinuria: a comprehensive analysis.

Eiko Yamakawa P, Perez Gomes C, Ribeiro Mendes A, Cesar Justino de Oliveira C, Porto Freitas F, Bettoni F Front Med (Lausanne). 2025; 12:1472186.

PMID: 40066167 PMC: 11891177. DOI: 10.3389/fmed.2025.1472186.


Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria.

Ussowicz M, Przystupski D, Mensah-Glanowska P, Piekarska A Front Immunol. 2025; 15():1521484.

PMID: 39840046 PMC: 11747312. DOI: 10.3389/fimmu.2024.1521484.


Identification of Paroxysmal Nocturnal Hemoglobinuria-Type Bone Marrow Mast Cells.

Savasan S, Ozdemir O, Gadgeel M Cureus. 2023; 15(9):e44919.

PMID: 37814756 PMC: 10560574. DOI: 10.7759/cureus.44919.


Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment.

Bravo-Perez C, Guarnera L, Williams N, Visconte V Medicina (Kaunas). 2023; 59(9).

PMID: 37763731 PMC: 10535188. DOI: 10.3390/medicina59091612.


The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center.

Pires da Silva B, Fonseca N, Catto L, Pereira G, Calado R Ann Hematol. 2022; 101(5):999-1007.

PMID: 35182190 PMC: 8993788. DOI: 10.1007/s00277-022-04797-9.


References
1.
Parker C . The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol. 2007; 35(4):523-33. DOI: 10.1016/j.exphem.2007.01.046. View

2.
Chen G, Kirby M, Zeng W, Young N, Maciejewski J . Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo. Exp Hematol. 2002; 30(7):774-82. DOI: 10.1016/s0301-472x(02)00811-1. View

3.
Brodsky R, Vala M, Barber J, Medof M, Jones R . Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1997; 94(16):8756-60. PMC: 23114. DOI: 10.1073/pnas.94.16.8756. View

4.
Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M . The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993; 259(5099):1318-20. DOI: 10.1126/science.7680492. View

5.
Karadimitris A, Manavalan J, Thaler H, Notaro R, Araten D, Nafa K . Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood. 2000; 96(7):2613-20. View